Phoenix Biotech Acquisiti... (PBAX)
5.85
0.37 (6.75%)
At close: Feb 14, 2024, 8:56 PM
6.75% (1D)
| Bid | n/a |
| Market Cap | 36.47M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -0.35 |
| PE Ratio (ttm) | -16.714285714285715 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 6,124 |
| Avg. Volume (20D) | 8,043 |
| Open | 5.50 |
| Previous Close | 5.48 |
| Day's Range | 4.91 - 5.95 |
| 52-Week Range | 4.12 - 12.80 |
| Beta | 0.04 |
About PBAX
Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. The company was incorporated in 2021 and is based in Oakland, ...
Industry Shell Companies
Sector Financial Services
IPO Date Nov 30, 2021
Employees NaN
Stock Exchange NASDAQ
Ticker Symbol PBAX